At a glance
ClinicalIndex Comparison RecordN/ACompleted· 250 enrolled
Drug / intervention
Trident® X3 Polyethylene Insertdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-label, Prospective, Post-market, Historically Controlled, Multi-center Clinical Evaluation of the Trident® X3 Polyethylene Acetabular Inserts.
In Brief
A clinical study evaluating Trident® X3 Polyethylene Insert for Arthroplasty, Replacement, Hip. Completed, enrolled 250 participants across 9 sites.
Detailed Summary
The primary objective of the study is to demonstrate the linear wear rates of the Trident® X3 polyethylene insert are superior to a polyethylene control group wear rate at 5 years postoperative. This measurement will be evaluated by comparing digitized images of serial radiographs obtained over a follow-up period of 5-years.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArthroplasty, Replacement, Hip
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2005
First PostedAug 2009
Primary CompletionJul 2012
Study CompletionDec 2016
TodayJul 2026
First PostedAug 13, 2009
Enrollment StartMay 1, 2005
Primary CompletionJul 1, 2012
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7.2 yearsPosted 16.9 years ago
Interventions
Trident® X3 Polyethylene Insertdevice
Trident® X3 Polyethylene Insert